Evidence map›Paper›PMID 40149677›Full record

ReviewBiomedicines2025

Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn's Disease: A Systematic Review and Meta-Analysis.

Nouran Alwisi, Rana Ismail, Hissa Al-Kuwari, Khalifa H Al-Ansari, Mohammed A Al-Matwi, Noor A Aweer, Wejdan N Al-Marri, Yousif Al-Kubaisi, Muneera Al-Mohannadi, Shahd Hamran and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Nouran AlwisiCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0009-0007-2785-9914
Rana IsmailCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0002-6446-1047
Hissa Al-KuwariCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0009-0004-0160-2684
Khalifa H Al-AnsariCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.
Mohammed A Al-MatwiCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.
Noor A AweerCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0002-1581-7211
Wejdan N Al-MarriCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.
Yousif Al-KubaisiCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.
Muneera Al-MohannadiDepartment of Gastroenterology and Hepatology, Hamad Medical Corporation, Doha P.O. Box 3050, Qatar.ORCID 0000-0001-6176-2883
Shahd HamranCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0009-0001-9892-0993
Suhail A R DoiCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0002-2630-2125
Habib H FarooquiCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.ORCID 0000-0002-3081-2929
Tawanda ChiveseCollege of Medicine, QU Health, Qatar University, Doha P.O. Box 2713, Qatar.

Funding

Qatar National Research Fund, Undergraduate Research Experience Program (UREP) (Grant ID: UREP31-179-3-047).
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Crohn’s disease (CD)interleukin inhibitorsintravenous (IV)meta-analysismonoclonal antibodies (mAbs)subcutaneous (SC)

Identifiers

PMID40149677
PMCPMC11940749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.